Clinical Trials in Denver

Showing 5581-5600 of 13,773 trials

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

NCT02386826

The purpose of this study is to determine whether the combination of two agents, INC280 and bevacizumab, is safe and effective when administered to patients with Glioblastoma Multiforme (GBM) who have progressed after receiving prior therapy or who have unresectable GBM.

Glioblastoma MultiformeGliosarcomaColorectal Cancer+1 more

SCRI Development Innovations, LLC65 participantsStarted Sep 2015

Denver, Colorado, United States • New Haven, Connecticut, United States • Kansas City, Missouri, United States +2 more locations

TERMINATEDPhase 26.3 miles

Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

NCT03752242

This is an exploratory Phase 2 trial of BMX-010 in patients with Acne Vulgaris which will be conducted in two parts.

Acne Vulgaris

BioMimetix JV, LLC2 participantsStarted Jan 2019

Englewood, Colorado, United States

TERMINATEDNA6.3 miles

Impact of Fever Prevention in Brain Injured Patients

NCT02996266

This study will assess the impact of fever prevention on fever burden and short- and long-term neurologic outcomes in brain injured patients. Half of the subjects will undergo fever prevention using a targeted temperature management system and half of the subjects will be treated for fever should it develop.

FeverIschemic StrokeIntracerebral Hemorrhage+1 more

C. R. Bard686 participantsStarted Jan 2017

Los Angeles, California, United States • Palo Alto, California, United States • Aurora, Colorado, United States +37 more locations

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.

Impact of Fever Prevention in Brain Injured Patients

Find Trials by Condition in Denver

Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers

Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Cannabidiol and Focus Study (CBD-Focus)

Subchondroplasty® Knee RCT

Development of the Virtual Unified Huntington's Disease Rating Scale

Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)

A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

PV Loop and Pulmonary Hypertension

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma

A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer

Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population